We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

News   Jun 30, 2017 | Original Story from the NIH

 
Repurposed Cancer Drug Could Treat Duchenne Muscular Dystrophy

Diaphragm muscle from SU9516 treated dystrophin deficient mouse showing nuclei (blue), myofibers (outlined in red) and regenerating muscle fibers (green). Credit: Burkin lab at the University of Nevada, Reno School of Medicine

 
 
 

RELATED ARTICLES

Cellular Component That Contributes to Lyme Arthritis Uncovered

News

Biochemist Brandon Jutras has discovered the cellular component that contributes to Lyme arthritis, a debilitating and extremely painful condition – the most common late stage symptom of Lyme disease.

READ MORE

Targeting Cell Membrane Proteins to Combat Drug Resistance

News

Certain membrane proteins specialize in transporting molecules out of cells – a problem for the efficacy of cancer medication and antibiotics. Now a team has investigated the transport mechanism of a bacterial membrane protein using an artificially produced antibody fragment.

READ MORE

Cartilage Ear 3D-printed Without Scaffolding

News

A new approach to bioprinting has been demonstrated in a study that successfully 3D-printed biological tissues without scaffolds using "ink" made up of only stem cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE